Conventional Ultrasound Versus Remote Ultraportable ulTrasound in the Context of Viral Hepatitis
- Conditions
- TeleradiologyHepatitis
- Interventions
- Device: TUP ultraportable US with teleradiology capacitiesDevice: CUS conventional ultrasound
- Registration Number
- NCT06571981
- Lead Sponsor
- Naik Vietti Violi
- Brief Summary
Comparison of abdominal US exam in patients with viral hepatitis between ultraportable US with teleradiology capacities (TUP) versus conventional ultrasound (CUS)
- Detailed Description
Primary Objective The investigation seeks primarily to determine the performance of abdominal US examinations realized with TUP and CUS based on defined imaging criteria Secondary Objectives Evaluate satisfaction and comfort and reproducibility of use of the ultraportable US
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 102
- Informed Consent signed by the subject
- All adult patients with viral hepatitis for which an ultrasound is planned
- Known or suspected non-compliance
- Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant,
- Previous enrollment into the current study
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Patients with viral hepatitis TUP ultraportable US with teleradiology capacities Every outpatient referred to the radiology department by a prescriber for abdominal US in the context of viral hepatitis Patients with viral hepatitis CUS conventional ultrasound Every outpatient referred to the radiology department by a prescriber for abdominal US in the context of viral hepatitis
- Primary Outcome Measures
Name Time Method Comparison of TUP versus CUS for abdominal imaging in patients with viral hepatitis according to US LI-RADS categories ) for liver lesions At the end of intervention LI RADS categories
No observation OR Only definitely benign observation(s) Observation(s) \< 10 mm in diameter, not definitely benign Observation(s) ≥ 10 mm in diameter, not definitely benign OR New thrombus in vein
- Secondary Outcome Measures
Name Time Method focal lesions At the end of intervention Yes/No
liver visualization scores At the end of intervention no or minimal limitations; moderate limitations; severe limitations
examination time At the end of intervention minutes
video quality At the end of intervention Adequate/Non Adequate
liver surface nodularity At the end of intervention Yes/No
caudate lobe dimensions At the end of intervention cm
biliary tract / gallbladder abnormalities At the end of intervention Yes/No
lymph nodes presence At the end of intervention Yes/No
free fluid At the end of intervention Yes/No
audio quality At the end of intervention Adequate/Non Adequate
portal flow velocity At the end of intervention cm/s
agreement rates between reports At the end of intervention Category 1: complete agreement/matching with teleradiologists reports; Category 2: minor discrepancy that would not impact patient management which included hedging terminology and ambiguous differences, for example fatty versus moderate fatty liver; Category 3: major discrepancy that would likely have an impact/change on patient management but would not lead to an adverse outcome for the patient; Category 4: major discrepancy that would impact patient management and lead to adverse outcomes for the patient.
patient's satisfaction At the end of intervention Yes/No
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Lausanne University Hospital
🇨🇭Lausanne, Vaud, Switzerland